Home/ Stocks/ CNTA

Centessa Pharmaceuticals plc American Depositary Shares

CNTA XNAS

$39.59 -0.02 (-0.05%) ▼ 15-min delayed

Open

$39.66

High

$39.75

Low

$39.53

Volume

682.4K

Market Cap

$6.13B

About Centessa Pharmaceuticals plc American Depositary Shares

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 129 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-79,241,000	$-0.52
FY 2025	$15.00M	$-197,532,000	$-1.46
Q3 2025	$0	$-54,891,000	$-0.41
Q2 2025	$0	$-50,343,000	$-0.38

Related Market News

No specific coverage for CNTA yet. Check out our latest market news or earnings calendar.

Get CNTA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Centessa Pharmaceuticals plc American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.